Used primarily in the synthesis of pharmaceutical agents, particularly as an intermediate in the production of immunomodulatory drugs. It plays a key role in the development of compounds that target cytokine modulation and angiogenesis inhibition. Commonly utilized in the preparation of analogs related to thalidomide and lenalidomide, it contributes to treatments for hematological cancers such as multiple myeloma and myelodysplastic syndromes. Its chiral structure makes it valuable for creating enantiomerically pure drugs with improved efficacy and reduced side effects. Also employed in research settings for exploring new therapeutic agents in oncology and inflammatory diseases.